Nebraska Medical Center (Site 1053) — Omaha, Nebraska

Nebraska Medical Center (Site 1053) is a clinical research site located in Omaha, Nebraska, United States 68105.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Medical Center (Site 1053) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Medical Center (Site 1053)?

Nebraska Medical Center (Site 1053) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Medical Center (Site 1053) conducted?

Nebraska Medical Center (Site 1053) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Nebraska Medical Center (Site 1053) accredited by Crixeo Health?

Nebraska Medical Center (Site 1053) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Medical Center (Site 1053)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.